Daiken Medical Co., Ltd. (TYO:7775)
Japan
· Delayed Price · Currency is JPY 501.00
+1.00 (0.20%)
Mar 12, 2025, 3:30 PM JST
Daiken Medical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 11, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 14,393 | 15,944 | 13,818 | 14,652 | 17,496 | 18,875 | Upgrade
|
| Market Cap Growth | 1.75% | 15.38% | -5.69% | -16.26% | -7.31% | 17.84% | Upgrade
|
| Enterprise Value | 13,760 | 15,955 | 14,329 | 15,410 | 18,475 | 19,740 | Upgrade
|
| Last Close Price | 501.00 | 545.61 | 455.45 | 463.19 | 533.67 | 556.62 | Upgrade
|
| PE Ratio | 13.62 | 16.14 | 19.41 | 17.63 | 25.92 | 21.97 | Upgrade
|
| PS Ratio | 1.44 | 1.64 | 1.51 | 1.72 | 2.23 | 2.21 | Upgrade
|
| PB Ratio | 1.95 | 2.27 | 2.09 | 2.27 | 2.83 | 3.10 | Upgrade
|
| P/TBV Ratio | 2.04 | 2.27 | 2.10 | 2.28 | 2.84 | 3.12 | Upgrade
|
| P/FCF Ratio | - | 11.45 | 17.47 | 15.74 | 58.32 | 14.83 | Upgrade
|
| P/OCF Ratio | - | 10.25 | 13.97 | 12.93 | 28.73 | 13.14 | Upgrade
|
| EV/Sales Ratio | 1.37 | 1.64 | 1.57 | 1.80 | 2.35 | 2.32 | Upgrade
|
| EV/EBITDA Ratio | 8.11 | 9.63 | 10.84 | 10.52 | 15.70 | 13.63 | Upgrade
|
| EV/EBIT Ratio | 9.04 | 11.06 | 13.58 | 13.39 | 20.06 | 16.52 | Upgrade
|
| EV/FCF Ratio | - | 11.45 | 18.12 | 16.55 | 61.58 | 15.51 | Upgrade
|
| Debt / Equity Ratio | 0.32 | 0.31 | 0.42 | 0.46 | 0.48 | 0.48 | Upgrade
|
| Debt / EBITDA Ratio | - | 1.29 | 2.08 | 2.00 | 2.51 | 2.01 | Upgrade
|
| Debt / FCF Ratio | - | 1.54 | 3.48 | 3.15 | 9.84 | 2.29 | Upgrade
|
| Asset Turnover | 0.89 | 0.89 | 0.83 | 0.79 | 0.72 | 0.78 | Upgrade
|
| Inventory Turnover | 4.27 | 3.91 | 3.67 | 3.28 | 3.47 | 3.58 | Upgrade
|
| Quick Ratio | 1.87 | 1.56 | 1.50 | 1.57 | 1.42 | 1.35 | Upgrade
|
| Current Ratio | 2.33 | 2.02 | 1.97 | 2.09 | 1.87 | 1.69 | Upgrade
|
| Return on Equity (ROE) | 14.79% | 14.51% | 10.92% | 13.16% | 11.01% | 14.50% | Upgrade
|
| Return on Assets (ROA) | 8.43% | 8.19% | 6.01% | 6.64% | 5.29% | 6.80% | Upgrade
|
| Return on Capital (ROIC) | 9.93% | 9.74% | 7.04% | 7.77% | 6.35% | 8.20% | Upgrade
|
| Return on Capital Employed (ROCE) | 18.28% | 18.82% | 13.80% | 14.82% | 12.44% | 16.56% | Upgrade
|
| Earnings Yield | 7.34% | 6.20% | 5.15% | 5.67% | 3.86% | 4.55% | Upgrade
|
| FCF Yield | 8.74% | 5.72% | 6.35% | 1.71% | 6.74% | Upgrade
| |
| Payout Ratio | 0.00% | 58.00% | 79.35% | 69.07% | 85.04% | 63.56% | Upgrade
|
| Buyback Yield / Dilution | 0.00% | 0.00% | 0.00% | - | - | 2.00% | Upgrade
|
| Total Shareholder Return | 3.59% | 0.00% | 0.00% | - | - | 2.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.